Annual report pursuant to Section 13 and 15(d)

Intangible Assets and Goodwill

v3.19.3.a.u2
Intangible Assets and Goodwill
12 Months Ended
Sep. 30, 2019
Intangible Assets and Goodwill [Abstract]  
Intangible Assets and Goodwill

Note 8 –Intangible Assets and Goodwill



Intangible Assets



Intangible assets acquired in the APP Acquisition included IPR&D, developed technology consisting of PREBOOST®  medicated wipes for the treatment of premature ejaculation, and covenants not-to-compete.  



The gross carrying amounts and net book value of intangible assets are as follows at September 30, 2019: 





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

523,172 

 

$

1,876,828 

Covenants not-to-compete

 

500,000 

 

 

208,333 

 

 

291,667 

Total intangible assets with finite lives

 

2,900,000 

 

 

731,505 

 

 

2,168,495 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

731,505 

 

$

20,168,495 



The gross carrying amounts and net book value of intangible assets are as follows at September 30, 2018:





 

 

 

 

 

 

 

 



Gross Carrying

 

Accumulated

 

Net Book



Amount

 

Amortization

 

Value

Intangible assets with finite lives:

 

 

 

 

 

 

 

 

Developed technology - PREBOOST®

$

2,400,000 

 

$

285,366 

 

$

2,114,634 

Covenants not-to-compete

 

500,000 

 

 

136,905 

 

 

363,095 

Total intangible assets with finite lives

 

2,900,000 

 

 

422,271 

 

 

2,477,729 

Acquired in-process research and development assets

 

18,000,000 

 

 

 —

 

 

18,000,000 

Total intangible assets

$

20,900,000 

 

$

422,271 

 

$

20,477,729 



Amortization is recorded over the projected related revenue stream for the PREBOOST® developed technology over 10 years and on a straight-line basis over seven years for the covenants not-to-compete. The amortization expense is recorded in selling, general and administrative expenses in the accompanying consolidated statements of operations.



Amortization expense was approximately $309,000 and $275,000, for the years ended September 30, 2019 and 2018, respectively. Based on finite-lived intangible assets recorded as of September 30, 2019, the estimated future amortization expense is as follows:





 

 



Estimated

Year Ending September 30,

Amortization Expense

2020

$

316,368 

2021

 

323,706 

2022

 

331,316 

2023

 

339,062 

2024

 

281,603 

Thereafter

 

576,440 

Total

$

2,168,495 

 

Goodwill



The carrying amount of goodwill at September 30, 2019 and 2018 was $6.9 million. There was no change in the balance during the years ended September 30, 2019 and 2018.